PAROS

Incepto

PAROS is an Artificial Intelligence Augmented Radiology solution for prostate MRI. It automatically segments the prostate to estimate its volume. The prostate lesions are automatically detected, segmented, characterized and shown in the PIRADS schema with their respective level of suspicion.

Information source: Vendor
Last updated: November 6, 2024

General Information

General
Product name	PAROS
Company	Incepto
Subspeciality	Abdomen
Modality	MR
Disease targeted	Prostate cancer
Key-features	Prostate segmentation and volumetrics, lesion detection, segmentation and characterization, PI-RADS support
Suggested use	"During: perception aid (prompting all abnormalities/results/heatmaps), report suggestion After: diagnosis verification"

Technical Specifications

Data characteristics
Population	Any patient over 18 years old for which a prostate MRI examination has been indicated
Input	T2 (axial or 3D), ADC map, Diffusion series with the highest B-value
Input format	DICOM
Output	Overlay of the segmented prostate and detected lesion(s), heatmap overlay which highlights suspicious areas in the prostate, prefilled report as DICOM SC.
Output format	DICOM
Technology
Integration	Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration via AI marketplace or distribution platform, Stand-alone third party application
Deployment	Cloud-based
Trigger for analysis	Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time	1 - 10 minutes

Regulatory

Certification
CE	Certified, IIa , MDR
FDA	No or not yet
Intended Use Statements
Intended use (according to CE)	PAROS is an image processing software intended to assist the physician's diagnosis for prostate cancer. This medical device software uses prostate MRI examinations in order to automatically provide data about prostate condition and cancerous lesions detection and characterization.

Market

Market presence
On market since	07-2024
Distribution channels	Incepto
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model	Subscription
Based on	Number of analyses

Evidence

Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers